ANNA WOODS: Open Payments
NPI 1912686296 · PHILADELPHIA, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$216 in 12 payments from 6 companies in 2025. Trend: 2023 $92 · 2024 $507 · 2025 $216
Food & beverage: $216
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $97 |
| Novo Nordisk Inc | 2 | $36 |
| Novartis Pharmaceuticals Corporation | 1 | $28 |
| Lundbeck LLC | 1 | $22 |
| ABBVIE INC. | 1 | $18 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $17 |
Products named: FARXIGA, Ozempic, AIRSUPRA, LEQVIO, REXULTI, VRAYLAR, Kerendia.
Industry payments across MS — which companies pay providers there.
